PharmaCyte Biotech Successfully Completes Pyrogenicity Testing

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box, …
(Orginal – Story lesen…)